Immediate Impact
52 standout
Citing Papers
Targeting PI3K/AKT/mTOR and MAPK Signaling Pathways in Gastric Cancer
2024 Standout
Glioblastoma Therapy: Past, Present and Future
2024 Standout
Works of Angelo Cambio being referenced
The AKT Inhibitor Perifosine in Biochemically Recurrent Prostate Cancer: A Phase II California/Pittsburgh Cancer Consortium Trial
2007
Clinical implications of neuroendocrine differentiation in prostate cancer
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Angelo Cambio | 92 | 211 | 120 | 102 | 15 | 383 | |
| Jay S. Belani | 88 | 240 | 103 | 81 | 13 | 443 | |
| A. Karim Touijer | 214 | 239 | 95 | 150 | 11 | 436 | |
| Waleed Hasan | 99 | 382 | 239 | 78 | 12 | 456 | |
| Joshua A. Halpern | 104 | 164 | 72 | 53 | 18 | 383 | |
| Jordan M. Kurta | 112 | 291 | 172 | 51 | 12 | 370 | |
| Ahmad BaniHani | 158 | 96 | 177 | 43 | 18 | 427 | |
| Raj P. Pal | 75 | 173 | 145 | 37 | 19 | 408 | |
| Yehoshua Gdor | 89 | 169 | 128 | 53 | 17 | 392 | |
| Jason Woo | 73 | 228 | 39 | 55 | 16 | 387 | |
| Trevor Dorkin | 122 | 133 | 190 | 153 | 23 | 440 |
All Works
Login with ORCID to disown or claim papers
Loading papers...